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Introduction
Tricuspid regurgitation (TR) is a common finding
after orthotopic heart transplantation, with a preva-
lence ranging from 47% to 98%.1 The presence of sig-
nificant TR has been suggested to have adverse effects
on cardiac performance and may eventually lead to
right-sided heart failure,2 which presents symptoms
such as fatigue and decreased exercise tolerance asso-
ciated with hepatomegaly, jugular venous distension
and lower-extremity edema. Such condition is refractory
to medical management and therefore requires surgical
therapy.3 The cause of TR seems multifactorial, with a
wide range of speculations, including: (1) distortion
of right atrial geometry following mid-atrial anasto-
mosis of donor and recipient right atrium (RA); (2)
ischemic injury of the papillary muscles at the time of
transplantation; (3) biopsy-induced injury to the tri-
cuspid valve (TV) apparatus; (4) size mismatch of the
donor heart and the pericardial cavity; (5) endocarditis;
(6) rejection; and (7) elevation of systolic pulmonary
artery pressure (SPAP) and pulmonary vascular resist-
ance.2,3 Among these speculations, the most widely
accepted one is iatrogenic TV apparatus damage induced
by endomyocardial biopsy (EMB),1–4 which is the gold
standard method for rejection detection after heart
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transplantation. If significant damage is inflicted on the
chordae or leaflet of TV during the biopsy procedure,
it might result in flail tricuspid valve (FTV) and cause
moderate or even severe TR. This study was to deter-
mine the prevalence of TR based on the experience of
our institution and to try to evaluate the likelihood 
of each of the previously proposed speculations of TR.
We also focused on the incidence of biopsy-induced
TV damage and its impact over the TR grade. We
hope this information can give us clues about the
most highly influencing cause of TR and help us to
prevent it.
Methods
Between July 1987 and March 2005, orthotopic heart
transplantations were performed in 50 patients. Eleven
patients were excluded from the study group, including
6 patients who survived < 1 month (3 patients died
within 7 days after heart transplantation, 2 patients died
within 14 days, and 1 patient expired on the 29th day
after transplantation) and 5 patients who were lost 
to follow-up within 3 months after transplantation.
The study group thus included 39 patients who
received serial right heart catheterization with EMB
and echocardiography. The end point of the study for
each patient was the mortality of the patient. Thirty
patients (77%) were male and 9 were female (23%),
with a mean age at transplantation of 46.6 ± 13.0 years
(range, 21–67). Patients underwent routine right-sided
cardiac catheterization and EMB at 1, 3, 6, 9, 12, 18
and 24 months after the operation and every year
thereafter.5 Once acute rejection was detected and the
patient received anti-rejection therapy, an additional
biopsy would be repeated 1 month after the treatment.
Otherwise, the biopsies were performed as clinically
indicated. The mean follow-up length was 42.9 ± 26.7
months, with a range of 6–96 months. A total of 373
biopsies were performed during our study period, with
each patient receiving 9.6 ± 6.4 biopsies. The right-
sided cardiac catheterization and EMB were carried
out by senior cardiologists who had gained experience
in such techniques. The pre-transplantation and post-
transplantation hemodynamic data including SPAP
and pulmonary vascular resistance index were collected
with right-sided cardiac catheterization. The left and
right ventricular ejection fractions were obtained with
first-pass nuclide angiography by injecting Tc-99m
DTPA via the ante-cubital vein, with data acquisition
by a gamma scintillation camera. The wall motion and
ejection fraction were then calculated from the data
obtained.
Standard mid-atrial anastomosis versus
bicaval anastomosis
We have used 2 different anastomosis techniques for
heart transplantation in our institution. The standard
mid-atrial anastomosis leaves generous right atrial cuffs
of donor and recipient hearts. The atrial cuffs are anas-
tomosed together with 3-0 prolene without creating
a tension between anastomoses. The bicaval anastomo-
sis method creates separate anastomoses of superior
vena cavae and inferior vena cavae between donor and
recipient hearts. Therefore, it leaves the structure and
geometry of the donor RA intact. In this study, 19
patients received mid-atrial technique and 20 patients
underwent bicaval technique. The severity of initial and
late TR, incidence of iatrogenic damage and the rate
of TR progression were compared between the 2 dif-
ferent anastomosis techniques.
EMB techniques
After obtaining a signed consent form from the patient,
we carried out the procedure in our cardiac catheteri-
zation room. The right internal jugular vein was punc-
tured and followed by guide wire and sheath introducer.
A 10-cm sheath with side arm and backbleed valve was
introduced over the guidewire. A Swan–Ganz catheter
was inserted with its tip placed at the pulmonary artery
under biplanar fluoroscopic guide (posterior–anterior
and lateral view), and hemodynamic data were obtained.
Under biplanar fluoroscopic guide (30° right anterior-
oblique and 60° left anterior-oblique views), a bioptome
was guided into the right ventricle and placed against
the interventricular septum. Operators withdrew the
bioptome about 1cm and opened the jaws, and then
the bioptome was readvanced into contact with endo-
myocardium. The jaws were closed with a brief delay
to sever the tissue, and then the bioptome was with-
drawn gently with its enclosed sample. The procedure
was repeated to obtain 5 pieces of specimen. The sheath
was removed and hemostasis achieved with direct com-
pression over the puncture site of the right internal
jugular vein. The puncture wound was covered with
sterilized gauze fixed with adhesive tape. The specimens
were examined and reported at the pathology labora-
tory of our institute. Between 1987 and 1991, biop-
sies were graded for rejection according to the system
of Billingham of Stanford University.6 Between 1991
and 2005, biopsies were graded for rejection accord-
ing to the Working Formulation of the International
Society for Heart and Lung Transplantation.7
Echocardiography
All patients received 2-dimensional echocardiography at
1 week after heart transplantation and on the next day
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following each EMB. The TVs were examined from all
views for the presence of iatrogenic damage over chor-
dae or leaflet. We defined extent of iatrogenic damage
as flail tricuspid leaflet, which was defined as prolapse
of leaflet of the TV with excursion of the leaflet edge
and/or free chords into the RA during systole,1 and
SCR, which meant rupture of chordae was evident but
excursion and prolapse of tricuspid leaflet was not
noted. The degree of TR was graded according to the
ratio of the maximum area of the regurgitant jet in
the RA to the area of the RA itself using color-flow
Doppler echocardiography.8 We defined regurgitant
jet area ratio < 10% as trivial TR, ratio 10–24% as mild
TR, ratio 24–49% as moderate TR, and ratio ≥ 50% as
severe TR. Change of TR grade ≥ 1 between the early
and latest cardiac echogram was taken as progression
of TR. Significant change of TR grade appearing
simultaneously with iatrogenic damage with tricus-
pid apparatus was regarded as biopsy-related TR 
progression.
Data analysis
The data were collected retrospectively from the
patients’ medical records. They were analyzed with SPSS
12.0 (SPSS Inc., Chicago, IL, USA) for statistical sig-
nificance. We used 2-sample t test for comparison of
continuous variables, Fisher’s exact test for categorical
variables, Kaplan–Meier method for survival rate, and
log-rank test for comparison of survival rate. We also
used logistic regression to assess risk factors for initial
and late significant TR, progression of TR grade as well
as iatrogenic damage of tricuspid apparatus. The data
were presented as mean±SD unless otherwise indicated.
A p value ≤ 0.05 was considered significant.
Results
Prevalence and severity distribution of TR
The characteristics of the 39 patients are summarized
in Table 1. Initially, 33 of 39 patients (84.6%) were
found to have TR; 23 patients (59.0%) had mild TR; 8
patients (20.5%) had moderate TR; and 2 (5.1%) had
severe TR. At the end of follow-up, TR was present in
36 out of 39 patients (92.3%), and the distribution of
severity shifted to mild/moderate/severe: 12 (30.8%)/
16 (41.0%)/8 (20.5%). Progression of TR was noted
in 14 patients (35.9%) at the end of follow-up.
Comparison between different severities of TR
We divided our patients into 2 groups according to
the severity of TR at the end of follow-up. The patients
in the 1st group had none to mild TR (n = 15), while
those in the second had moderate to severe TR (n =
24). We collected variables, including demographic
characteristics, hemodynamic characteristics, operative
method and time, follow-up length, total biopsy num-
ber, iatrogenic damage of TV, number of rejection
episodes, symptoms of right-sided heart failure (includ-
ing hepatomegaly, jugular venous distension, and lower-
extremity edema), and 4-year survival, and compared
them between the 2 groups, with the results summa-
rized in Table 2.
The moderate–severe TR group had significantly
longer follow-up length (29.5 ± 16.6 months vs. 51.2 ±
28.7 months, p = 0.011), higher rate of iatrogenic
damage of TV (7% vs. 71%, p < 0.001), and higher
prevalence of right side heart failure (0% vs. 21%, 
p = 0.02). The total biopsy number also was greater in
this group (6.5 ± 3.9 vs. 11.46 ± 7.04), and the differ-
ence also reached statistical significance (p = 0.018).
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Table 1. Patient population profile of the study group
Recipient body weight (kg) 61.9 ± 11.6 (37–89)
Preoperative LVEF (%) 18.8 ± 6.6 (11–23)
Preoperative RVEF (%) 26.7 ± 9.7 (10–37)
Preoperative SPAP (mmHg) 44.5 ± 13.2 (24–69)




Total bypass time 180.0 ± 56.1 (110–360)





Postoperative SPAP (mmHg) 35.3 ± 9.8 (19–61)
Postoperative LVEF (%) 49.8 ± 10.5 (26–73)
Postoperative RVEF (%) 50.9 ± 8.8 (26–67)
Follow-up length (mo) 42.9 ± 26.7 (6–96)
Total biopsy number 9.6 ± 6.4 (1–28)
Iatrogenic damage of TV 18 (46.2%)
Number of biopsies when 6.1 ± 4.3 (1–14)
iatrogenic damage occurred
Number of rejection episodes 0.6 ± 2.1 (0–10)
Symptoms of right-sided heart 5 (12.8%)
failure
4-year survival 65.5%
Data displayed as mean ± SD (range) or number (%) of patients. LVEF = left
ventricular ejection fraction; RVEF = right ventricular ejection fraction; 
TR = tricuspid regurgitation; SPAP = systolic pulmonary artery pressure; 
PVR = pulmonary vascular resistence; TV = tricuspid valve.
As to the survival rate, the moderate–severe TR group
had 75.5% in 4-year survival, in contrast to 48.8% in the
none–mild TR group, and they were not statistically
different (Figure 1).
Comparison between different anastomosis
techniques
We divided the 39 patients into 2 groups according to
their anastomosis technique. The 1st group consisted
of 19 patients who received mid-atrial anastomosis
technique and the 2nd group was composed of 20
patients who underwent bicaval anastomosis. We com-
pared the initial and late TR grade as well as the rates
of iatrogenic damage and progression of TR between
the groups. All of the items we compared did not reach
statistical significance. The results are summarized in
Table 3.
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Table 2. Comparison between patients with different severity of tricuspid regurgitation
None/mild Moderate/severe p
No. of patients 15 24
Gender (M/F) 9/6 21/3
Age (yr) 44.0 ± 13.7 48.3 ± 12.5 NS
Dilative cardiomyopathy (%) 46.7 37.5 NS
Ischemic cardiomyopathy (%) 53.3 62.5 NS
Preoperative LVEF (%) 18.6 ± 3.3 18.9 ± 8.2 NS
Preoperative RVEF (%) 25.5 ± 8.2 27.7 ± 11.0 NS
SPAP (mmHg) 43.9 ± 14.5 44.9 ± 12.9 NS
PVR (dynes s/cm5) 360.7 ± 369.5 395.2 ± 407.4 NS
Bicaval anastomosis (%) 53% 50% NS
Total bypass time (min) 189.5 ± 45.6 174.8 ± 61.6 NS
Total ischemic time (min) 165.1 ± 37.9 176.7 ± 64.5 NS
Postoperative SPAP (mmHg) 31.5 ± 7.3 37.4 ± 10.5 NS
Postoperative LVEF (%) 54.2 ± 10.5 47.9 ± 10.1 NS
Postoperative RVEF (%) 53.7 ± 8.3 49.6 ± 9.1 NS
Rejection episodes 0.8 ± 2.1 0.5 ± 2.0 NS
Follow-up length (mo) 29.5 ± 16.6 51.2 ± 28.7 0.011
Total biopsy number 6.5 ± 3.9 11.5 ± 7.0 0.018
Data displayed as mean ± SD or number (%) of patients. LVEF = left ventricular ejection fraction; RVEF = right ventricular ejection fraction; NS = not significant;
SPAP = systolic pulmonary artery pressure; PVR = pulmonary vascular resistance.


















Figure 1. Survival curves of different tricuspid regurgitation (TR)
grades. The upper straight line represents patients with moder-
ate to severe TR and the lower dotted line is the survival curve of
patients with none to mild TR.
Table 3. Comparison between different anastomosis methods
Mid-atrium Bicaval p
No. of patients 19 20
Initial TR grade NS
None–mild 74% 75%
Moderate–severe 26% 25%
Late TR grade NS
None–mild 37% 40%
Moderate–severe 63% 60%
Iatrogenic damage 37% 55% NS
Progression of TR 36% 35% NS
TR = tricuspid regurgitation; NS = not significant.
Comparison between different severity of
iatrogenic damage
The 39 patients were then divided into 3 groups
according to the severity of iatrogenic damage inflicted
by EMB over the TV at the end of each follow-up.
Twenty-one patients did not sustain any iatrogenic dam-
age over tricuspid apparatus, and they were members
of the 1st group. Eight patients were found to have SCR
and 10 patients had FTV, and they were brought
under the 2nd and the 3rd groups, respectively. We com-
pared the distribution of TR severity, the rate of TR
progression, the number of total biopsies, the number
of biopsies when iatrogenic damage occurred, the
presence of symptoms of right-sided heart failure, and
the 4-year survival rate between the 3 groups. As to the
distribution of the TR grade, the no-damage group
had only 33% of patients with TR grade above mod-
erate. In contrast, 88% of patients in the SCR group
and 100% of patients in the FTV group had moderate
to severe TR, and the difference was statistically sig-
nificant (p = 0.001). The no-damage group had only
10% of patients with TR progression while the SCR
group had 62.5% and FTV group had 70% of patients
with progressed TR grade. The difference was also sig-
nificant (p=0.001). The FTV and SCR groups also
had significant higher number (p = 0.003) of total
biopsies along the follow-up, with the values of 14.2 ±
9.1 and 11.6 ± 3.5, respectively. The iatrogenic dam-
age occurred after 6.6 ± 3.2 biopsies in the SCR group
and 5.7 ± 5.1 biopsies in the FTV group, and the dif-
ference was not significant between the 2 groups. The
rate of symptoms of right-sided heart failure showed
no difference among the 3 groups. We finally come to
4-year survival of the 3 groups. Much to our surprise,
the no-damage group had only 34.2%, while the SCR
group had 100% and the FTV group had 89.9% 4-year
survival. We will discuss this unexpected finding in a
latter section of this article. The results of comparison
among the 3 groups are summarized in Table 4, and
the survival curves are shown in Figure 2.
Mortality
Eleven patients expired during the follow-up period.
Seven patients (63.6%) died of sepsis due to infections
of various microorganisms, and 3 (27.3%) sustained
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Table 4. Comparison between patients with different severity of iatrogenic damage on tricuspid valve (TV) apparatus
None SCR FTV p
No. of patients 21 8 10
Late TR grade 0.001
None–mild 67% 12% 0%
Moderate–severe 33% 88% 100%
Progression of TR 10% 62.5% 70% 0.001
Total number of biopsies 6.6 ± 4.0 11.6 ± 3.5 14.2 ± 9.1 0.003
Number of biopsies when damage occurred NA 6.6 ± 3.2 5.7 ± 5.1 NS
Symptoms of right-sided heart failure 14% 0% 20% NS
4-year survival 34.2% 100% 88.9% 0.006
Data displayed as mean ± SD, number or percentage of patients. SCR = small chordae rupture; FTV = flail tricuspid valve; NA = not available; NS = not significant.


















Figure 2. Survival curves of different severity of tricuspid valve
(TV) damage: the upper straight line represents the small chor-
dae rupture (SCR) group; the middle dotted line represents the flail
tricuspid valve (FTV) group; the lower dashed line represents the
no-damage group.
acute rejection and subsequent cardiogenic shock. The
remaining 1 patient expired suddenly at our institute,
and the cause of mortality could not be clarified, even
after autopsy.
Risk factor assessment
We calculated risk factors for initial and late significant
TR, progression of TR grade as well as iatrogenic dam-
age of tricuspid apparatus with logistic regression.
However, only total biopsy number ≥10 reached signifi-
cance as a risk factor for both iatrogenic damage of TV
apparatus (p=0.002), and progression of TR (p=0.017).
All of the risk factors we tested for both initial and
late TR grade failed to reach statistical significance.
Discussion
Prevalence and severity of TR after cardiac
transplantation
High prevalence of TR following orthotopic cardiac
transplantation has been documented in many stud-
ies.1–4 TR is not a rare finding in normal subjects, and
the prevalence has been reported from 24% to 83%.2,9,10
However, the severity of TR in normal subjects is
mostly trivial to mild. In contrast, a significant por-
tion of patients receiving orthotopic heart transplan-
tation is found to have moderate to severe TR, with
the percentage ranging from 5.6% to 85%.1–4 Moreover,
Hausen et al4 noted the severity of TR progressed
with time after heart transplantation in a retrospective
study including 251 patients with follow-up length as
long as 4 years. In this study, the prevalence of TR
was 84.6% immediately after the transplantation, and
it increased to 92.3% at the end of the follow-up. The
proportion of patients with moderate to severe TR also
increased from 25.6% to 61.5%. The results were com-
patible with those of other series. Therefore, prevalence
and the severity of TR after orthotopic heart transplan-
tation seem to have the tendency to progress with time.
Causes of TR
Many hypotheses have been proposed for the causes
of TR after cardiac transplantation.
Hausen et al4 proposed that if preoperative SPAP
exceeds 55 mmHg and postoperative pulmonary vas-
cular resistence (PVR) is in excess of 240 dynes s/cm5,
patients are more likely to experience early postoperative
TR. However, Williams et al2 found that early post-
operative pulmonary hypertension resolved promptly
in most post-transplantation patients in their study of
72 orthotopic cardiac transplant recipients.2 In other
studies, the statistical data also failed to prove the 
correlation between postoperative TR and preoperative
SPAP as well as postoperative PVR.4,8 In our study, no
significant differences of postoperative SPAP and PVR
were found between different severities of TR, and
logistic regression also failed to prove SPAP and PVR
as significant risk factors for early and late TR. Thus,
we deem that pulmonary hypertension may not be the
major cause of post-transplant TR.
At least 3 different anastomosis techniques have
been applied in orthotopic heart transplantation. They
are mid-atrial, bicaval, and total techniques. As men-
tioned earlier, mid-atrial technique connects donor
and recipient atrial cuffs, and bicaval technique makes
anastomoses between superior and inferior vena cavae
of recipient and donor hearts. Total technique involves
complete excision of recipient atria with separate bi-
caval end-to-end anastomoses, as well as pulmonary
venous anastomoses.11 Morgan and Edwards reviewed
39 studies related to comparison of outcome of all
these 3 techniques and concluded that bicaval tech-
niques provided anatomic and functional advantages
such as decreased valvular insufficiency.11 However,
in this study, we found there was no statistical differ-
ence in the initial and late TR grades, incidence of
iatrogenic damage as well as rate of TR progression.
In addition, Yankah et al3 noted the incidence of TR
after Lower and Shumway technique was very low in
their study of 1,124 orthotopic cardiac transplantations
at the Deutsches Herzzentrum Berlin. Therefore, it is
our opinion that the different anastomosis techniques
of orthotopic heart transplantation may not play a key
role in the development and progression of TR after
orthotopic heart transplantation.
EMB was initially noted to be associated with
post-transplantation TR in the early 1990s. Braverman
et al12 reported 5 patients with TV chordae rupture in
a study of 81 patients receiving orthotopic heart trans-
plantation. More reports related to iatrogenic damage
of tricuspid apparatus induced by EMB were published
later. We have summarized the rate of flail tricuspid and
TR prevalence as well as TR severity of these studies in
Table 5.1–4,13 Williams et al2 found the presence of
FTV was frequently associated with the development
of severe TR after heart transplantation. Hausen et al4
noted significant correlation between the number of
biopsy and the development of TR. In the present study,
we found the presence of iatrogenic damage of tricus-
pid apparatus was significantly related to the presence of
moderate to severe TR (p = 0.001) and progression of
TR (p = 0.001). Moreover, the total biopsy number
was also significantly correlated to the occurrence of
iatrogenic damage (p = 0.003). We deem the iatrogenic
damage of tricuspid apparatus induced by EMBs might
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be the most highly influencing factor for the develop-
ment and progression of TR after heart transplantation.
Acute or chronic rejection was once suspected as a
cause of TR after orthotopic heart transplantation. In
our series, the rejection episodes were not statistically
different between patients with different severity of
TR (Table 2). Nonetheless, rejection episodes do really
influence the development of TR through the neces-
sity of more frequent EMB. At most heart transplanta-
tion institutes, additional EMB is performed if suspected
rejection episodes appear. As previously mentioned, the
chance of iatrogenic damage of tricuspid apparatus
would increase due to this reason.
Relationship between survival and 
severity of TR
Hausen et al4 noted that mortality increased with the
severity of TR after orthotopic heart transplantation.
Nath et al14 studied 5,223 patients without heart trans-
plantation for 4 years and concluded that increasing TR
severity was associated with worse survival. However,
the survival curve we obtained in this study was surpris-
ingly beyond our expectations. Shown in Figures 1 and
2, the survival curves of the patients with lesser degree
of TR and TV damage seemed worse than for patients
with a high degree of TR and TV damage. The only
explanation for this unthinkable finding lies in the cause
of mortality of our subjects. Eleven patients expired
during the follow-up period; 7 patients died of infec-
tion, while 3 patients died of acute rejection. Most of
the mortality was not directly related to right-sided
heart function and the severity of TR. Conversely, the
patients who survived longer would inevitably receive
more EMBs and thus were more likely to sustain iatro-
genic damage of tricuspid apparatus. Therefore, these
survival curves just tell us that the patients who sur-
vived longer were more likely to sustain TR, but not
that the TR made them live longer. We do believe that
TR severity impacts survival after orthotopic heart
transplantation in the long run. Nonetheless, this dif-
ference may not be obvious in our small patient group
and relatively short follow-up period.
Prophylactic measurements for TV damage
induced by EMB
From the literature we reviewed and the results we
obtained in our series, it is our opinion that iatrogenic
damage over tricuspid apparatus induced by EMB plays
the key role in the progression of post-transplantation
TR. Measurements for prevention of iatrogenic dam-
age induced by EMB were tested and reported in
some studies. Williams et al2 thought the incidence of
biopsy-related damage could be decreased by minimiz-
ing the number of passages of the bioptome across the
tricuspid apparatus. Therefore, they used 45-cm long
sheath in their routine EMB procedure and success-
fully reduced the incidence of FTV from 41% to 6%
and mean grade of TR from 2 to 1.1 From previous
literature4,12,15 and the results of our series, we con-
clude that the total number of EMBs was significantly
correlated to the incidence of biopsy-related damage
over TVs and chordae. Yankah et al3 studied 647
patients receiving orthotopic heart transplantation at
Deutsches Herzzentrum Berlin. They reduced the fre-
quency of EMB with the aid of intramyocardial elec-
trocardiography (IMEG), which is a noninvasive method
to monitor the amplitude of the QRS-complex by tele-
metric bipolar pacemaker during the sleeping phase of
a patient through a normal telephone system at home.
EMBs were only arranged when doubtful IMEG and
echocardiographic data emerged. They successfully
reduced the frequency of EMB from 14.4 to 4.8 biop-
sies/patient/year. Combined with the utilization of a
45-cm long sheath bioptome, this technology decreased
the rate of FTV to 2.3% and prevalence of severe TR to
2.5%. This result was outstanding compared to other
studies we have reviewed here (Table 5).
Surgical management for TR after orthotopic
heart transplantation
Most low-grade TR following cardiac transplantation
can be left alone unless symptoms of right-sided heart
failure develop. However, when severe TR and FTV are
present, surgical management for TR should be consid-
ered. Messika-Zeitoun et al16 studied 60 patients with
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Table 5. Comparison of tricuspid regurgitation (TR) prevalence and severity between different studies
No. of patients TR prevalence (%) Moderate & severe TR (%) FTV (%)
Chan et al1 336 67 34 NA
Williams et al2 72 98 32 14
Yankah et al3 647 20.1 5.6 2.3
Hausen et al4 251 96 85 13.9
Tucker et al13 181 NA 33 21
This study 39 93 61 25
FTV = flail tricuspid valve; NA = not available.
TR induced by FTV. They found patients with flail
tricuspid were associated with increased 10-year mor-
tality (39 ± 10%) and TR-related morbidity (75 ± 15%).
Poor outcome of medical treatment was confirmed by
TR-related event rate (69 ± 9%). They concluded sur-
gical management for TR with FTV had low mortality
(3%) and excellent symptomatic improvement (88%).
Stahl et al17 first reported 5 patients with severe TR and
right-sided heart failure after heart transplantation
receiving TV repair as well as replacement and the oper-
ations successfully improved TR grade without mortality
in 1995. Yankah et al3 also operated on 17 patients with
severe TR after heart transplantation. Eleven patients
received prosthetic valve replacement and 6 patients
underwent TV repair. Forty percent of the patients
receiving the operation were expected to survive more
than 10 years. Therefore, surgical intervention should be
beneficial for patients with severe TR and impending
right-sided heart failure after heart transplantation.
TR is a fairly common finding in patients receiving
orthotopic heart transplantation. The percentage of
patients with moderate to severe TR after heart trans-
plantation is higher compared to that of normal sub-
jects, and it tends to increase with time. The iatrogenic
damage over TV induced by EMB might play the cen-
tral role in facilitating progression of TR. The incidence
of damage over TV could be reduced through mini-
mizing the frequency of EMB and utilization of 45-cm
long sheath bioptome. In the face of severe TR with
FTV as well as right-sided heart failure, surgical interven-
tion on TVs has reasonable surgical mortality and pro-
vides symptomatic relief as well as survival improvement.
Study limitations
There were several limitations in our series. First, the
heart transplantation team in our institute was estab-
lished around 1995, and many patients who received
heart transplantation before this were lost to follow-
up due to inadequate education and communication
with the patients after the transplantation. The patients
who were excluded from the study group increased
the bias of the study. Our series was a small-group
study, and the follow-up lengths were only feasible for
intermediate outcome analysis. Statistical biases were
easily created in such condition. Therefore, the results
of our study should be taken conservatively. Finally,
many variables were unable to be precisely controlled,
such as personnel in charge of EMB and cardiac echo-
gram. Further prospective study with larger patient
group and longer follow-up is necessary to determine
whether the length of biopsy sheath and frequency are
able to influence chances of iatrogenic damage of TV
apparatus as well as their impact on long-term survival.
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